These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6731676)

  • 41. The immune response during a Strongyloides ratti infection of rats.
    Wilkes CP; Bleay C; Paterson S; Viney ME
    Parasite Immunol; 2007 Jul; 29(7):339-46. PubMed ID: 17576363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant cDNA clones for immunodiagnosis of strongyloidiasis.
    Ramachandran S; Thompson RW; Gam AA; Neva FA
    J Infect Dis; 1998 Jan; 177(1):196-203. PubMed ID: 9419188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Avidity as a criterion for diagnosis of human strongyloidiasis increases specificity of IgG ELISA.
    Bosqui LR; Gonzaga HT; Gonçalves-Pires MDRF; de Paula FM; Almeida RS; Pavanelli WR; Conchon-Costa I; Costa-Cruz JM; da Costa IN
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):262-264. PubMed ID: 28969935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis.
    Eamudomkarn C; Sithithaworn P; Sithithaworn J; Kaewkes S; Sripa B; Itoh M
    Parasitol Res; 2015 Jul; 114(7):2543-51. PubMed ID: 25877389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, immunological and epidemiological aspects of strongyloidiasis in an endemic area of Brazil.
    de Messias IT; Telles FQ; Boaretti AC; Sliva S; Guimarres LM; Genta RM
    Allergol Immunopathol (Madr); 1987; 15(1):37-41. PubMed ID: 3604841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serological cross-reactivity between Strongyloides venezuelensis and Syphacia muris in Wistar rats (Rattus norvegicus).
    de Sousa JE; de Carvalho EF; Levenhagen MA; de Faria LS; Gonçalves-Pires Mdo R; Costa-Cruz JM
    Parasitol Int; 2016 Apr; 65(2):137-45. PubMed ID: 26601618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis.
    Mota-Ferreira DM; Gonçalves-Pires Mdo R; Júnior AF; Sopelete MC; Abdallah VO; Costa-Cruz JM
    Acta Trop; 2009 Feb; 109(2):103-7. PubMed ID: 19007741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice.
    Kerepesi LA; Nolan TJ; Schad GA; Lustigman S; Herbert DR; Keiser PB; Nutman TB; Krolewiecki AJ; Abraham D
    J Infect Dis; 2004 Apr; 189(7):1282-90. PubMed ID: 15031798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strongyloides infection in rodents: immune response and immune regulation.
    Breloer M; Abraham D
    Parasitology; 2017 Mar; 144(3):295-315. PubMed ID: 26905057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatal disseminated strongyloidiasis in a Vietnam War veteran.
    Hakim SZ; Genta RM
    Arch Pathol Lab Med; 1986 Sep; 110(9):809-12. PubMed ID: 3755889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laboratory detection of strongyloidiasis: IgG-, IgG4 - and IgE-ELISAs and cross-reactivity with lymphatic filariasis.
    Norsyahida A; Riazi M; Sadjjadi SM; Muhammad Hafiznur Y; Low HC; Zeehaida M; Noordin R
    Parasite Immunol; 2013; 35(5-6):174-9. PubMed ID: 23448095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of human strongyloidiasis by immunofluorescence, using Strongyloides ratti and S. stercoralis larvae.
    Grove DI; Blair AJ
    Am J Trop Med Hyg; 1981 Mar; 30(2):344-9. PubMed ID: 7015889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgG avidity in differential serodiagnosis of human strongyloidiasis active infection.
    Gonzaga HT; Ribeiro VS; Feliciano ND; Manhani MN; Silva DA; Ueta MT; Costa-Cruz JM
    Immunol Lett; 2011 Sep; 139(1-2):87-92. PubMed ID: 21699917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA).
    Sato Y; Takara M; Otsuru M
    Trans R Soc Trop Med Hyg; 1985; 79(1):51-5. PubMed ID: 3992642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.
    Neva FA; Filho JO; Gam AA; Thompson R; Freitas V; Melo A; Carvalho EM
    J Infect Dis; 1998 Dec; 178(6):1856-9. PubMed ID: 9815251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of immune complexes and evaluation of alcoholic individuals' serological profile in the diagnosis of strongyloidiasis.
    Gonçalves AAS; Lopes CA; Gonzaga HT; Gonçalves ALR; Levenhagen MA; Oliveira LCM; Costa-Cruz JM
    Parasitol Int; 2018 Oct; 67(5):644-650. PubMed ID: 29933043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of virus-specific IgG and IgM antibody response in patas monkeys experimentally infected with Delta herpesvirus by enzyme-linked immunosorbent assay.
    Achilli G; Sarasini A; Revello MG; Torsellini-Gerna M; Gerna G; Iltis JP; Madden DL
    Microbiologica; 1984 Oct; 7(4):287-97. PubMed ID: 6096678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis.
    Satoh M; Toma H; Sato Y; Kikuchi M; Takara M; Shiroma Y; Kiyuna S; Hirayama K
    Am J Trop Med Hyg; 1999 Oct; 61(4):668-71. PubMed ID: 10548308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the immune response against Strongyloides venezuelensis in antigen-immunized or previously infected mice.
    Fernandes A; Pereira AT; Eschenazi PD; Schilter HC; Sousa AL; Teixeira MM; Negrão-Corrêa D
    Parasite Immunol; 2008 Mar; 30(3):139-49. PubMed ID: 18179627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
    Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
    Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.